Liver News

Treatment of Hepatitis C A Systematic Review

April 8, 2019 | By | Publications

Abstract

Hepatitis C virus (HCV) infects more than 185 million individuals worldwide. Twenty percent of patients chronically infected with HCV progress to cirrhosis. New, simpler therapeutics using direct-acting antivirals that target various stages of the HCV life cycle are in development to eradicate HCV without concomitant interferon.

See full article here